Wolfe Research initiated coverage on Tyra Biosciences
Stocks in this Quantisnow insightHealth Care
Historical context for TYRA
Across the 13 sessions after earlier TYRA headlines, the stock closed higher 8 times and lower 5 times, with a median move of 1.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TYRA | SPY |
|---|---|---|---|
| May 13, 2026 | Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights | +3.8% | +0.6% |
| May 8, 2026 | Tyra Biosciences to Participate in Upcoming Investor Conferences | +4.3% | +0.8% |
| Apr 17, 2026 | Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors | +1.3% | +1.2% |
| Apr 15, 2026 | Guggenheim initiated coverage on Tyra Biosciences with a new price target | -0.9% | +0.8% |
| Apr 6, 2026 | Canaccord Genuity initiated coverage on Tyra Biosciences with a new price target | -1.7% | +0.5% |
| Mar 3, 2026 | Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights | +1.5% | -0.9% |
Quantisnow market dataNASDAQ
TYRA
Tyra Biosciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for TYRA
Full TYRA profile on Quantisnow Follow TYRA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time